Tech Company Financing Transactions
ImmuONE Funding Round
On 3/13/2025, ImmuONE raised $800 thousand in investment from Mercia Ventures, Midlands Engine Investment Fund and Pioneer Group.
Transaction Overview
Company Name
Announced On
3/13/2025
Transaction Type
Venture Equity
Amount
$800,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to develop its capabilities, target new sectors such as agrichemicals and automotive, and expand its team with the appointment of two new scientists.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Sycamore House, 16 Leyden Road
Stevenage, SG1 2BP
UK
Stevenage, SG1 2BP
UK
Phone
Website
Email Address
Overview
Our solution at ImmuONE is to build and provide lab-grown human (essentially, cells in a dish) lung platforms and testing services for assessing the safety of chemicals. We meet industry needs for a relevant and predictive human testing technology and provide tailored in-house testing for all of our clients as needed. Our solution is win-win-win -- we support more medicines to market, we enable safer human chemical exposure thresholds as well as reducing unnecessary animal testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Abigail Martin
Browse more venture capital transactions:
Prev: 3/13/2025: Omni Analytics venture capital transaction
Next: 3/13/2025: Disputed.ai venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs